Home › Companies › DAY ONE BIOPHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and DAY ONE BIOPHARMACEUTICALS INC.’s Form 8-K, filed May 24, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 23, 2024: 5 items on DAY ONE BIOPHARMACEUTICALS INC.’s Form 8-K, filed May 24, 2024: 5 passed (calculated).
Significant dissent: 1 director (20.0% against).
Notable dissent: 1 director (15.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Explore DAY ONE BIOPHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are DAY ONE BIOPHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 24, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jeremy Bender, Ph.D., M.B.A. | 62,935,239 | -- | -- | 11,080,216 | 4,390,159 | 85% | Passed (calculated) | — |
| Elect Director: Habib Dable, M.B.A. | 73,883,045 | -- | -- | 132,410 | 4,390,159 | 99.8% | Passed (calculated) | — |
| Elect Director: Saira Ramasastry, M.S., M.Phil. | 59,183,371 | -- | -- | 14,832,084 | 4,390,159 | 80% | Passed (calculated) | — |
| 2. The ratification of appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. | 78,312,286 | 91,361 | 1,967 | -- | -- | 99.9% | Passed (calculated) | — |
| 3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | 73,212,768 | 612,128 | 190,559 | -- | 4,390,159 | 99.2% | Passed (calculated) | — |
Source: DAY ONE BIOPHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 24, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
174 asset managers disclosed a vote on at least one DAY ONE BIOPHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DAY ONE BIOPHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Habib Dable
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Habib Dable, M.B.A.”): 73,883,045 for, 132,410 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
| Global X | 33,901 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 17,030,072 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Jeremy Bender
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeremy Bender, Ph.D., M.B.A.”): 62,935,239 for, 11,080,216 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,348,881 | 0 | 0 | 1,844 | For |
| Dimensional | 0 | 0 | 0 | 602,169 | Withhold |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 131,714 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 110,000 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 91,858 | Withhold |
| Lincoln Financial | 51,700 | 0 | 0 | 32,913 | Mixed |
| RBB FUND, INC. | 13,255 | 0 | 0 | 51,462 | Mixed |
| ALPS ETF Trust | 0 | 0 | 0 | 61,631 | Withhold |
| Advisors' Inner Circle Fund III | 57,536 | 0 | 0 | 178 | For |
| ProShares | 0 | 0 | 0 | 45,154 | Withhold |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 21,771 | 0 | 0 | 20,272 | Mixed |
| Brinker Capital Destinations Trust | 2,218 | 0 | 0 | 32,705 | Mixed |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
| Global X | 33,901 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 15,683,812 for, 1,292,340 withheld, 53,920 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Saira Ramasastry
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Saira Ramasastry, M.S., M.Phil.”): 59,183,371 for, 14,832,084 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350 | 0 | 0 | 1,349,375 | Withhold |
| Dimensional | 0 | 0 | 0 | 602,169 | Withhold |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 112,282 | 0 | 0 | 63,000 | Mixed |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 131,714 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 110,000 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 91,858 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 84,613 | Withhold |
| RBB FUND, INC. | 13,255 | 0 | 0 | 51,462 | Mixed |
| ALPS ETF Trust | 0 | 0 | 0 | 61,631 | Withhold |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 45,154 | Withhold |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 21,771 | 0 | 0 | 20,272 | Mixed |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 34,923 | Withhold |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
| Global X | 33,901 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 14,210,609 for, 2,765,543 withheld, 53,920 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Approval, on a non-binding advisory basis, of the compensation of our named executive officers.
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.”): 73,212,768 for, 612,128 against, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 0 | 0 | 0 | 175,018 | Withhold |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,536 | 178 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 17,017,345 for, 12,727 against, 175,018 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 14,000,000 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 7,747,198 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 3,732,355 | 0 | 0 | 0 | For |
| Fidelity | 3,007,329 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 2,558,563 | 0 | 0 | 0 | For |
| State Street | 2,362,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,250,451 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 2,157,178 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,765,009 | 0 | 0 | 0 | For |
| BlackRock | 1,619,255 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,485,862 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 1,371,131 | 0 | 0 | 0 | For |
| Janus Henderson | 1,268,095 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 1,169,829 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 906,020 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 643,388 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 461,188 | 0 | 0 | 0 | For |
| Charles Schwab | 457,652 | 0 | 0 | 0 | For |
| Northern Trust | 303,374 | 52 | 0 | 0 | For |
| Candriam S.C.A. | 290,000 | 0 | 0 | 0 | For |
| Wellington | 242,679 | 0 | 0 | 0 | For |
| Samsara BioCapital, LLC | 196,425 | 0 | 0 | 0 | For |
| Nicholas Investment Partners, LP | 195,960 | 0 | 0 | 0 | For |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 184,668 | 0 | 0 | Against |
Institutional-manager reports, all 133 managers: 54,109,992 for, 314,683 against, 193 not voted, 26,675 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Selection, on a non-binding advisory basis, of whether future advisory votes on the compensation of our named executive officers should be every one, two or three years.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| AMG FUNDS | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| RBB FUND, INC. | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Tema ETF Trust | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 57 managers: 12,562 for, 16,397,296 1 year, 620,214 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 7,747,198 | 0 | Abstain |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| VIKING GLOBAL INVESTORS LP | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | -- |
| TimesSquare Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Atlas Venture Life Science Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MAVERICK CAPITAL LTD | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Candriam S.C.A. | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Samsara BioCapital, LLC | 0 | 0 | 0 | 0 | -- |
| Nicholas Investment Partners, LP | 0 | 0 | 0 | 0 | -- |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 129 managers: 77,313 for, 7,747,198 abstained, 193 not voted, 46,328,522 1 year, 97,364 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 100.0% for (June 22, 2023 meeting) ▼ 0.1 pts
Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.
DAY ONE BIOPHARMACEUTICALS INC.’s own tally for this item (“2. The ratification of appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.”): 78,312,286 for, 91,361 against, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,623,302 | 0 | 0 | 0 | For |
| BlackRock | 2,654,524 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 2,039,003 | 0 | 0 | 0 | For |
| Fidelity | 1,777,196 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,751,257 | 0 | 0 | 0 | For |
| State Street | 1,350,725 | 0 | 0 | 0 | For |
| Dimensional | 602,169 | 0 | 0 | 0 | For |
| Charles Schwab | 457,642 | 0 | 0 | 0 | For |
| Equitable | 175,282 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 175,018 | 0 | 0 | 0 | For |
| TIAA | 151,563 | 0 | 0 | 0 | For |
| AMG FUNDS | 137,900 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 131,714 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 111,530 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 110,000 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 91,858 | 0 | 0 | 0 | For |
| Lincoln Financial | 84,613 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 64,717 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,631 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 57,714 | 0 | 0 | 0 | For |
| ProShares | 45,154 | 0 | 0 | 0 | For |
| Tema ETF Trust | 44,423 | 0 | 0 | 0 | For |
| Brighthouse | 42,043 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 34,923 | 0 | 0 | 0 | For |
| Northern Trust | 34,181 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 17,205,090 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TimesSquare Capital Management, LLC | 1,411,807 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,411,807 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 87,389,859 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.29% |
| 2 | BlackRock | 3.04% |
| 3 | FRANKLIN STRATEGIC SERIES | 2.33% |
| 4 | Fidelity | 2.03% |
| 5 | T. Rowe Price | 2.00% |
| 6 | State Street | 1.55% |
| 7 | Dimensional | 0.69% |
| 8 | Charles Schwab | 0.52% |
| 9 | Equitable | 0.20% |
| 10 | Simplify Exchange Traded Funds | 0.20% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | New York Life | 16.02% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.87% |
| 3 | FRANKLIN ADVISERS INC | 4.27% |
| 4 | Fidelity | 3.44% |
| 5 | VIKING GLOBAL INVESTORS LP | 2.93% |
| 6 | State Street | 2.70% |
| 7 | T. Rowe Price | 2.58% |
| 8 | PICTET ASSET MANAGEMENT SA | 2.47% |
| 9 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.02% |
| 10 | BlackRock | 1.85% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| AI Day 1 LLC | 12,929,322 | 14.79% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| FMR (Fidelity) | 10,097,668 | 11.55% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 9,001,455 | 10.30% | Form 13F, quarter ended March 31, 2024 |
| RA Capital Management, L.P. | 7,809,852 | 8.94% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Entities affiliated with Atlas Venture | 7,608,394 | 8.71% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Vanguard Group | 6,181,329 | 7.07% | Form 13F, quarter ended March 31, 2024 |
| Franklin Templeton | 3,806,790 | 4.36% | Form 13F, quarter ended March 31, 2024 |
| Jeremy Bender, Ph.D., M.B.A. | 3,193,143 | 3.65% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| State Street | 2,894,883 | 3.31% | Form 13F, quarter ended March 31, 2024 |
| Samuel Blackman, M.D., Ph.D. | 2,457,292 | 2.81% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
Percentages above are of 87,389,859 shares outstanding, as reported by DAY ONE BIOPHARMACEUTICALS INC. on its Form 10-Q dated May 1, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At DAY ONE BIOPHARMACEUTICALS INC.'s shareholder meeting held May 23, 2024, in the 2023-2024 proxy season, 174 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,602 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the compensation of our named executive officers. — FOR was 99.2% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: DAY ONE BIOPHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 24, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DAY ONE BIOPHARMACEUTICALS INC.’s 10-Q dated May 1, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
DAY ONE BIOPHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Proxy Votes Now, “DAY ONE BIOPHARMACEUTICALS INC. 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/day-one-biopharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.